Introduction Indications for inhaled corticosteroids (IC) in combination with long-acting
bronchodilators (LABD) are well defined in clinical practice guidelines. However, there are …

Despite the fact that the recommendations of the main clinical guidelines have restricted the
indications for inhaled corticosteroids in chronic obstructive pulmonary disease (COPD) …

Introduction Identifying the variables that guide decision-making in relation to the use of
inhaled corticosteroids (ICS) can contribute to the appropriate use of these drugs. The …

Inhaled corticosteroids (ICS) combined with bronchodilators can reduce the frequency of
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …

Global Initiative for Chronic Obstructive Lung Disease guidelines support the prescription of
fixed combination inhaled corticosteroids (ICS) and long-acting β-agonists in symptomatic …

Introduction: Current guidelines recommend the use of inhaled long-acting bronchodilators,
inhaled corticosteroids (ICSs) and their combinations for maintenance treatment of moderate …

Background Inhaled corticosteroids are increasingly being used in patients with chronic
obstructive lung disease (COPD), but their effectiveness is disputed. The aim of this study …

Purpose Inhaled corticosteroids (ICS) are frequently used to treat chronic obstructive
pulmonary disease (COPD) outside the current recommendations. Our aim was to describe …

Background It has been suggested that withdrawal of inhaled corticosteroids (ICS) in COPD
patients on maintenance treatment results in deterioration of symptoms, lung function and …

Evidence and guidelines are becoming increasingly clear about imbalance between the
risks and benefits of inhaled corticosteroids (ICSs) in patients with COPD. While selected …